Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19

Mantke et al., demonstrated the use of virusPHIX-P9™ for stablising SARS-CoV-2 Antigen and use by 258 participants across 27 countries for Lateral flow rapid antigen tests, automated point-of-care-tests and laboratory ELISA / immunoassays. 


Antigen testing has become integral in the ongoing monitoring and detection of COVID-19. 

Independent and extensive comparative evaluations using data from external quality assessment studies to evaluate test performance are crucial.

Click the button below to read more on this EQA scheme. The scheme was established to assess the sensitivity of antigen tests and the impact of different COVID-19 strains on their performance.

Share this post